Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,101.20
(
-0.39%
)
Dow Jones
49,490.03
(
0.00%
)
Brent Oil
98.15
(
1.48%
)
Bitcoin
77,550.71
(
-0.88%
)
News Focus
News Focus
Post# of 822508
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: branster post# 346922

Tuesday, 01/12/2021 4:15:41 PM

Tuesday, January 12, 2021 4:15:41 PM

Post# of 822508
If Merck was "engaged" with NWBO it could have been handled like with NVCR.

NVCR announced the partnership. Merck is running the trial combo in rGMN with Keytruda+Optune while NVCR is running the the nGBM combo trial.

I guess Merck is to stupid to realize that Optune is a scam.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News